Harrow Inc (HROW)
16.76
+0.60
(+3.71%)
USD |
NASDAQ |
May 17, 16:00
16.77
+0.01
(+0.06%)
After-Hours: 20:00
Harrow Accounts Payable (Quarterly): 12.57M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 12.57M |
December 31, 2023 | 21.42M |
September 30, 2023 | 12.77M |
June 30, 2023 | 10.51M |
March 31, 2023 | 13.79M |
December 31, 2022 | 6.44M |
September 30, 2022 | 7.043M |
June 30, 2022 | 8.038M |
March 31, 2022 | 5.595M |
December 31, 2021 | 5.174M |
September 30, 2021 | 4.671M |
June 30, 2021 | 3.882M |
March 31, 2021 | 5.176M |
December 31, 2020 | 3.932M |
September 30, 2020 | 5.691M |
June 30, 2020 | 5.78M |
March 31, 2020 | 7.527M |
December 31, 2019 | 7.702M |
September 30, 2019 | 8.144M |
June 30, 2019 | 6.943M |
March 31, 2019 | 6.143M |
December 31, 2018 | 4.966M |
September 30, 2018 | 5.931M |
June 30, 2018 | 4.663M |
March 31, 2018 | 3.883M |
Date | Value |
---|---|
December 31, 2017 | 3.885M |
September 30, 2017 | 4.035M |
June 30, 2017 | 3.344M |
March 31, 2017 | 3.92M |
December 31, 2016 | 3.538M |
September 30, 2016 | 3.795M |
June 30, 2016 | 3.956M |
March 31, 2016 | 4.253M |
December 31, 2015 | 3.407M |
September 30, 2015 | 1.917M |
June 30, 2015 | 1.181M |
March 31, 2015 | 1.145M |
December 31, 2014 | 0.787M |
September 30, 2014 | 0.8042M |
June 30, 2014 | 0.7501M |
March 31, 2014 | 0.3571M |
December 31, 2013 | 0.3119M |
September 30, 2013 | 0.6979M |
June 30, 2013 | 0.7647M |
March 31, 2013 | 0.5031M |
December 31, 2012 | 0.3425M |
September 30, 2012 | 0.5949M |
June 30, 2012 | 0.4235M |
March 31, 2012 | 0.2567M |
December 31, 2011 | 0.2747M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
3.882M
Minimum
Jun 2021
21.42M
Maximum
Dec 2023
8.140M
Average
6.993M
Median
Accounts Payable (Quarterly) Benchmarks
Durect Corp | 0.782M |
Aquestive Therapeutics Inc | 10.52M |
Cyclacel Pharmaceuticals Inc | 3.543M |
Stereotaxis Inc | 3.307M |
Cara Therapeutics Inc | 4.978M |